NAPRA

The National Association of Pharmacy Regulatory Authorities (NAPRA) is pleased to announce the launch of its newly redesigned bilingual website. With its updated visual style, thoughtfully considered content and streamlined navigation for faster access...

The interim recommendations made by the National Drug Scheduling Advisory Committee (NDSAC) on September 18, 2022 that:
Brimonidine tartrate ophthalmic solution in concentrations up to and including 0.025%, used for the relief of redness of the eye due to minor eye irritations caused by environmental allergies, dryness and fatigue for adults of 18 years and older remain...

My name is Jocelyn Bonti-Ankomah. I am a third-year pharmacy student at the University of Waterloo where I had the pleasure of completing my third co-op rotation at the National Association of Pharmacy and Regulatory Authorities (NAPRA). I had the privilege...

The National Association of Pharmacy Regulatory Authorities (NAPRA) is pleased to announce the publication of NAPRA’s Annual Report 2021, titled “Navigating a World in Transition”.
The report reflects NAPRA’s continued support to its members, the pharmacy regulatory authorities across Canada, as they confronted the pressures of the second year of the COVID-19 pandemic on the profession of pharmacy, which saw, among other challenges...